Invizyne Technologies Inc. (NASDAQ:IZTC – Get Free Report)’s stock price was down 2% during mid-day trading on Wednesday . The company traded as low as $11.76 and last traded at $11.76. Approximately 1,088 shares changed hands during trading, a decline of 97% from the average daily volume of 37,647 shares. The stock had previously closed at $12.00.
Invizyne Technologies Stock Down 2.0%
The business’s 50 day moving average is $9.94 and its 200-day moving average is $11.89.
Institutional Trading of Invizyne Technologies
A hedge fund recently bought a new stake in Invizyne Technologies stock. BNP Paribas Financial Markets purchased a new position in shares of Invizyne Technologies Inc. (NASDAQ:IZTC – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 2,113 shares of the company’s stock, valued at approximately $35,000.
About Invizyne Technologies
Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.
See Also
- Five stocks we like better than Invizyne Technologies
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion
- The Most Important Warren Buffett Stock for Investors: His Own
- Despite Pullback, Rocket Lab Still Looks Primed for a Breakout
- What is the Euro STOXX 50 Index?
- Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook
Receive News & Ratings for Invizyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invizyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
